Vimarsana
Biggest News Aggregation in the World

Page 10 - Trevena News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trevena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trevena Today - Breaking & Trending Today

Contrasting Trevena (NASDAQ:TRVN) & Merck & Co., Inc. (NYSE:MRK) - Vimarsana News

Contrasting Trevena (NASDAQ:TRVN) & Merck & Co., Inc. (NYSE:MRK)

Trevena (NASDAQ:TRVN – Get Rating) and Merck & Co., Inc. (NYSE:MRK – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Analyst Ratings This is a summary of current ratings […]

Source: wkrb13.com
Trevena (TRVN) Scheduled to Post Earnings on Thursday - Vimarsana News

Trevena (TRVN) Scheduled to Post Earnings on Thursday

Trevena (NASDAQ:TRVN – Get Rating) will issue its quarterly earnings data before the market opens on Thursday, March 30th. Parties interested in registering for the company’s conference call can do so using this link. Trevena Price Performance NASDAQ:TRVN opened at $0.75 on Wednesday. Trevena has a one year low of $0.65 and a one year […]

FY2022 EPS Estimates for Trevena, Inc. Lifted by Oppenheimer (NASDAQ:TRVN) - Vimarsana News

FY2022 EPS Estimates for Trevena, Inc. Lifted by Oppenheimer (NASDAQ:TRVN)

Trevena, Inc. (NASDAQ:TRVN – Get Rating) – Research analysts at Oppenheimer raised their FY2022 earnings per share estimates for Trevena in a note issued to investors on Wednesday, May 11th. Oppenheimer analyst J. Jones now expects that the biopharmaceutical company will earn ($0.30) per share for the year, up from their previous estimate of ($0.39). […]

Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group - Vimarsana News

Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group

CHESTERBROOK, Pa., March 31, 2022 -- Trevena, Inc. , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system ... | March 31, 2022

Short Interest in Trevena, Inc. (NASDAQ:TRVN) Declines By 20.9% - Vimarsana News

Short Interest in Trevena, Inc. (NASDAQ:TRVN) Declines By 20.9%

Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 3,600,000 shares, a decline of 20.9% from the February 13th total of 4,550,000 shares. Currently, 2.3% of the shares of the stock are short sold. Based on an […]